As of 3:59pm ET
| -0.01 / -0.09%|
The 3 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 14.00, with a high estimate of 15.00 and a low estimate of 11.50. The median estimate represents a +25.34% increase from the last price of 11.17.
The current consensus among 3 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.